Repligen Corporation, a life sciences company focused on bioprocessing technology, entered into a definitive agreement to acquire privately held Metenova AB, a manufacturer of magnetic mixers for pharmaceutical and biotechnology use. Metenova is projected to generate revenues of $24 million to $25 million for fiscal year 2023, led by its magnetic mixing and drive train technologies that are widely used by global biopharmaceutical companies and contract development and manufacturing organizations...